APA

Fauster A., Rebsamen M., Huber K. V. M., Bigenzahn J. W., Stukalov A., Lardeau C., Scorzoni S., Bruckner M., Gridling M., Parapatics K., Colinge J., Bennett K. L., Kubicek S., Krautwald S., Linkermann A. & Superti-Furga G. (20160218). A cellular screen identifies ponatinib and pazopanib as inhibitors of necroptosis. : Cell death & disease.

Chicago

Fauster A, Rebsamen M, Huber K V M, Bigenzahn J W, Stukalov A, Lardeau C-H, Scorzoni S, Bruckner M, Gridling M, Parapatics K, Colinge J, Bennett K L, Kubicek S, Krautwald S, Linkermann A and Superti-Furga G. 20160218. A cellular screen identifies ponatinib and pazopanib as inhibitors of necroptosis. : Cell death & disease.

Harvard

Fauster A., Rebsamen M., Huber K. V. M., Bigenzahn J. W., Stukalov A., Lardeau C., Scorzoni S., Bruckner M., Gridling M., Parapatics K., Colinge J., Bennett K. L., Kubicek S., Krautwald S., Linkermann A. and Superti-Furga G. (20160218). A cellular screen identifies ponatinib and pazopanib as inhibitors of necroptosis. : Cell death & disease.

MLA

Fauster A, Rebsamen M, Huber K V M, Bigenzahn J W, Stukalov A, Lardeau C-H, Scorzoni S, Bruckner M, Gridling M, Parapatics K, Colinge J, Bennett K L, Kubicek S, Krautwald S, Linkermann A and Superti-Furga G. A cellular screen identifies ponatinib and pazopanib as inhibitors of necroptosis. : Cell death & disease. 20160218.